Surface pressure was measured at 21 ± 1°C for 2000 sec, and monitored using a NIMA Technology tensiometer, model PS3 (Coventry, UK). The water subphase was buffered with 30 mM Tris-HCl (pH 7.5). Recombinant lysenin proteins were injected into the aqueous sub-phase at a concentration range of 0.5-40 μM.
Lytic Activity of Lysenin Against HEK293 Cells
To analyze the pore-forming activities of lysenin WT and lysenin V88C/Y131C in mammalian cells, we measured the plasma membrane's permeability to calcein as previously described [1] , with some modification. HEK293 cells in a 12-well plate (0.5 × 10 6 cells/500 μL of TBS) were incubated for 1 h at 37 °C in darkness with 1 μM calcein-AM (Sigma). After washing with TBS, cells were incubated with various concentrations of lysenin WT and lysenin V88C/Y131C with or without 10 mM DTT. After centrifugation (500 × g for 5 min), we measured the amount of calcein released using a JASCO FP 6500 spectrofluorimeter at an Ex/Em of 460/517 nm. The calcein efflux induced by recombinant proteins was expressed as the percentage of the maximal efflux determined in the presence of Triton X-100.
Blue Native-Polyacrylamide Gel Electrophoresis (BN-PAGE)
Lipid-bound samples were prepared according to procedure described for HDX measurements. Before application onto polyacrylamide gradient 4-20% PROTEAN TGX Precast Protein Gels (Bio-Rad) protein samples were supplemented with blue native sample buffer to final concentrations of 10% glycerol, 0.5 % bromophenol blue, and 31 mM Tris-HCl, pH 6.8. Protein were visualized by colloidal Coomassie G-250 staining. Figure S8 . Amino acid sequence of recombinant lysenin. Lysenin sequence is marked in black; mutation sites (V88 and Y131) are underlined and marked in red; N-terminal His tag, thrombin cleavage site, internal T7 epitope tag derived from pET28 vector are marked in blue.
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